Program review can help quality risk management live up to the promise of ICH Q9.
Michael J. Shea
Advertisement
Michael J. Shea is the director of engineering at GxP Systems, Cork, Republic of Ireland. Email: michaeljshea@gxpsystems.com
Articles by Michael J. Shea
Advertisement
Latest Updated Articles
Assessing a Risk Management ProgramSeptember 1st 2014
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
3
The BioPharm Brief: Base Editing Hits Its Mark in Sickle Cell, a Phase 3 Win in Sjögren’s, and Off-the-Shelf CAR-T in Lupus
4
Beam's Risto-cel Meets Primary Endpoint in Sickle Cell Trial
5